EHC
Encompass Health Corporation
NYSE Healthcare United States
126,56 $US
+1.79% today
+18.98% YTD · +2.35% 1Y
3
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
17
Hedge funds tracked
Latest available SEC 13F filings
81
/ 100
VERY STRONG

Analysis Encompass Health Corporation (EHC) — Kairos Score 81/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Encompass Health Corporation

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Key info

👔
CEO
Mr. Mark J. Tarr
📍
HQ
9001 Liberty Parkway, Birmingham, AL, 35242, United States
👥
Employees
29 699
💰
Market cap
12 485 571 584,00 $US
📊
P/E
21.2
💸
Dividend yield
0.68%

🕴️ Insider activity (90 days)

3 transactions — 0 buys and 2 sales reported by Encompass Health Corporation executives.

PA
Price Andrew L
Chief Accounting Officer · 2026-08-31
Sell
DJ
Darby John Patrick
EVP, Gen Counsel & Secretary · 2026-08-31
Other
DJ
Darby John Patrick
EVP, Gen Counsel & Secretary · 2026-08-31
Sell

🏦 Hedge Funds

17 institutional funds report a position on EHC in their latest SEC quarterly filing.

VANGUARD GROUP INC
BlackRock, Inc.
PRICE T ROWE ASSOCIATES INC /MD/
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC

📰 Recent news

15 recent articles on EHC.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Encompass Health Corporation

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of EHC on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 3 insider transactions over 90 days
✅ All 17 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year